Refractive Surgery News

SAN DIEGO — At the American Society of Cataract and Refractive Surgery, Uday Devgan, MD, discusses the Juvene IOL from LensGen, which has been implanted in 95 eyes in the clinical trial to date. The unique design of the IOL aims to provide 3 D to 4 D of visual range without visual disturbances.

SAN DIEGO — Intraoperative aberrometry calculations more accurately determined IOL power than did two standard IOL formulas in certain patients, according to a study presented here.

SAN DIEGO — Incoming ASCRS president Nick Mamalis, MD, believes he knows what the next disruptive IOL technology will be: refractive indexing.

SAN DIEGO — Anterior elevation, posterior elevation, pachymetry, underlying pathology and long-term effect on patients are five key elements that Kendall E. Donaldson, MD, MS, integrates into her topographic assessment when planning refractive surgery.

SAN DIEGO ― At the American Society of Cataract and Refractive Surgery, Jay S. Pepose, MD, discusses the newly published algorithm developed by the ASCRS Cornea Committee for the diagnosis and treatment of ocular surface disease before cornea- or lens-based refractive surgery.

SAN DIEGO — Many conceptions about dry eye and LASIK can be challenged by data, according to a speaker.

VANCOUVER, British Columbia — At the Association for Research in Vision and Ophthalmology meeting, Daniel R. Neal, PhD, discusses how to convert objective data such as wavefront measurements to subjective measures such as visual acuity in order to better communication between physicians and patients.

VANCOUVER, British Columbia — At the Association for Research in Vision and Ophthalmology meeting, Desmond Adler, PhD, Avedro’s vice president of research and development, discusses the company’s epi-on cross-linking procedure for keratoconus and PiXL (photorefractive intrastromal cross-linking) for presbyopia correction.

Both visual acuity and refractive results improved in patients undergoing deep intrastromal arcuate keratotomy with in situ keratomileusis for treatment of high astigmatism after keratoplasty, according to a study.

Bausch + Lomb will begin a clinical trial series of its Technolas Teneo excimer laser for vision correction surgery, the company announced in a press release.